With Sahin, a BioNTech cofounder, leaving for a new mRNA company, Oelkers will lead the biotech as it aims to become a global cancer player.
Capricor is asking the FDA to approve its treatment for Duchenne, but advisers have questioned the data the company presented.
Today's biotech news includes: Moderna's imminent FDA vaccine decision, TCGX launches $400M Asia biotech fund, and more
Experts say increased administrative burdens will reduce the number of eligible beneficiaries, so Medicaid cuts aren't a myth. They are just obscured.
Play: What's the word? Test your knowledge with today's mini crossword
